particularly stark for breast cancer, which fell 51.8 percent during the lockdown compared to previous levels The number of cancers diagnosed weekly in the United States fell by almost fifty percent during March and April compared to the recent average, a study said Tuesday, the latest to examine the impacts of COVID-19 lockdowns. Emergency room...
Tag: <span>COVID-19</span>
Post
Artificial intelligence-enhanced ECGs may speed heart failure diagnosis and treatment
Circulation: Arrhythmia and Electrophysiology Journal Report DALLAS, August 4, 2020 — When people seek emergency care for shortness of breath, a routine electrocardiogram (ECG or EKG) enhanced by artificial intelligence (AI) is better than standard blood tests at determining if the cause is heart failure, according to new research published today in Circulation: Arrhythmia and...
Post
Nasal spray approved for treating suicidal people
by Cynthia Koons Johnson & Johnson’s Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about COVID-19’s effect on the mental health of Americans. The Food and Drug Administration approval means the quick-acting nasal spray will be available to people with suicidal thoughts and a plan...
Post
Rise of TB
‘The Biggest Monster’ Is Spreading. And It’s Not the Coronavirus. Tuberculosis kills 1.5 million people each year. Lockdowns and supply-chain disruptions threaten progress against the disease as well as H.I.V. and malaria. It begins with a mild fever and malaise, followed by a painful cough and shortness of breath. The infection prospers in crowds, spreading...
Post
China: New DEADLY Bunyavirus Re-emerges as the Country Grapples with Bubonic Plague Death
7 August 2020, 5:59 am EDT By Jamie P. Tech Times Coronavirus has not yet ended. Worse, there is still no official vaccine nor cure to counter its attack on humans. However, China recently found out that another virus revolves around the country, has the same characteristics as the SARS-CoV-2. The virus is called ‘Novel...
Post
The yin and yang of inflammation controlled by a single molecule
Researchers from the Perelman School of Medicine at the University of Pennsylvania have now identified a protein called histone deacetylase 3 (HDAC3) as the orchestrator of the immune system’s inflammation response to infection. By using both specially cultured cells and small animal models, HDAC3 was found to be directly involved in the production of agents...
Post
Lung Link
Harvard Medical School researchers at Boston Children’s Hospital and Brigham and Women’s Hospital will soon begin testing an existing drug, dornase alfa, in patients with severe COVID-19 pneumonia and respiratory failure. The randomized, controlled clinical trial aims to enroll 60 adults and children over age 3 who require mechanical ventilation. Dornase alfa, also known as...
Post
Strong link found between abnormal liver tests and poor COVID-19 outcomes
New Haven, Conn. — Researchers at the Yale Liver Center found that patients with COVID-19 presented with abnormal liver tests at much higher rates than suggested by earlier studies. They also discovered that higher levels of liver enzymes — proteins released when the liver is damaged — were associated with poorer outcomes for these patients,...
Post
COVID-19 may have a longer incubation period, suggests probability analysis of Wuhan cases
Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE By applying the renewal theory in probability to reduce recall bias in initial case reports, scientists have come up with a new estimate for the incubation period of COVID-19....
Post
Intranasal vaccine platform has potential for more effective vaccines, fewer side effects
by University of Chicago Medical Center The ongoing COVID-19 pandemic is shining a bright spotlight on vaccine development. As numerous vaccines race through clinical trials, physicians and researchers continue to work on developing new vaccine technologies to generate the most effective vaccines with the fewest side effects. A new proof-of-concept study by researchers at the...